Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomicsplatform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.

Biotechnology

Therapeutics

Belharra Therapeutics

Jeff Jonker

Lisa Allen

Olesya Ulanovskaya

Jessica Alexander

Kelly Chow

Sherry Niessen

Justin Ernst

Sean Buchanan

Sharon Tetlow

Rachel Lane

Gary O’Neill

The Leadership Team at Belharra Therapeutics is responsible for setting the strategic direction of the company, driving innovation in their photoaffinity-based chemoproteomics platform, and overseeing operations across various departments. This team comprises experienced professionals in business, science, and operations who collaborate to ensure the company meets its scientific and commercial goals while fostering a productive and innovative work environment.

Leadership Team

Research and Development

Operations

Leadership Team

About

Team members

Other teams at Belharra Therapeutics

Research and Development

Operations